CRIS Current Research Information System

VIALE, PIERLUIGI
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 29.019
NA - Nord America 27.177
EU - Europa 23.062
SA - Sud America 1.961
AF - Africa 1.320
OC - Oceania 98
Continente sconosciuto - Info sul continente non disponibili 14
AN - Antartide 1
Totale 82.652
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 26.644
SG - Singapore 7.990
CN - Cina 7.344
VN - Vietnam 6.827
IT - Italia 6.675
GB - Regno Unito 4.356
DE - Germania 2.726
NL - Olanda 2.192
HK - Hong Kong 1.945
SE - Svezia 1.895
BR - Brasile 1.383
IN - India 1.241
FR - Francia 1.182
KR - Corea 1.017
RU - Federazione Russa 943
BD - Bangladesh 673
IE - Irlanda 631
FI - Finlandia 532
JP - Giappone 513
UA - Ucraina 396
CI - Costa d'Avorio 373
ZA - Sudafrica 336
CA - Canada 283
AR - Argentina 241
BG - Bulgaria 226
ID - Indonesia 214
TG - Togo 212
CH - Svizzera 211
EE - Estonia 201
AT - Austria 178
JO - Giordania 168
PH - Filippine 168
ES - Italia 137
TH - Thailandia 133
MX - Messico 131
IQ - Iraq 127
PL - Polonia 103
BE - Belgio 96
TR - Turchia 96
TW - Taiwan 96
AU - Australia 86
SC - Seychelles 84
NG - Nigeria 81
PK - Pakistan 81
EC - Ecuador 71
SA - Arabia Saudita 68
CL - Cile 62
RO - Romania 55
CO - Colombia 52
LT - Lituania 48
MY - Malesia 46
PE - Perù 44
IR - Iran 42
PY - Paraguay 40
GR - Grecia 39
UZ - Uzbekistan 37
HR - Croazia 35
MA - Marocco 35
VE - Venezuela 35
PT - Portogallo 32
CD - Congo 27
EG - Egitto 27
TN - Tunisia 26
AE - Emirati Arabi Uniti 25
CZ - Repubblica Ceca 24
DK - Danimarca 23
LB - Libano 23
DZ - Algeria 21
KE - Kenya 19
NP - Nepal 18
HU - Ungheria 17
KZ - Kazakistan 17
JM - Giamaica 16
RS - Serbia 16
SK - Slovacchia (Repubblica Slovacca) 16
AZ - Azerbaigian 15
CR - Costa Rica 15
IL - Israele 15
AL - Albania 14
UY - Uruguay 14
ET - Etiopia 13
PA - Panama 13
BO - Bolivia 12
GT - Guatemala 11
HN - Honduras 11
OM - Oman 11
DO - Repubblica Dominicana 10
LV - Lettonia 10
BA - Bosnia-Erzegovina 9
TT - Trinidad e Tobago 9
AO - Angola 8
BH - Bahrain 8
CY - Cipro 8
EU - Europa 8
LY - Libia 8
MD - Moldavia 8
GH - Ghana 7
MK - Macedonia 7
AM - Armenia 6
KG - Kirghizistan 6
Totale 82.479
Salva come PNG Salva come JPEG
Città #
Singapore 5.634
Southend 3.850
Ashburn 3.248
Fairfield 2.268
Hefei 1.984
San Jose 1.823
Hong Kong 1.817
Ho Chi Minh City 1.628
Chandler 1.438
Hanoi 1.396
Santa Clara 1.256
Bologna 1.101
Woodbridge 1.040
Seattle 975
Seoul 931
Wilmington 927
Houston 909
Frankfurt am Main 867
Princeton 806
Cambridge 756
Beijing 752
Ann Arbor 737
Boardman 718
Eygelshoven 676
Kerkrade 648
Dublin 625
Dong Ket 612
Milan 563
New York 552
Lauterbourg 540
Los Angeles 498
Council Bluffs 432
Tokyo 423
Dallas 411
Rome 391
Abidjan 373
Helsinki 363
Nanjing 288
Buffalo 265
Westminster 256
Da Nang 243
Padova 227
Berlin 221
Lomé 212
Sofia 207
Bengaluru 206
São Paulo 202
Haiphong 199
Redondo Beach 191
Chicago 176
Florence 171
San Diego 171
Turin 170
Shanghai 169
Amman 164
Jinan 162
Saint Petersburg 146
Guangzhou 139
Nuremberg 137
Munich 131
Bern 129
Jakarta 126
Redmond 125
Naples 118
Shenyang 114
Bremen 112
Changsha 112
Lappeenranta 103
Des Moines 102
Amsterdam 99
Dearborn 97
Nanchang 93
Vienna 92
London 91
Brescia 90
Jacksonville 88
The Dalles 86
Hebei 85
Montreal 85
Phoenix 85
Brussels 83
Genoa 76
Orem 76
Redwood City 76
San Francisco 76
Verona 76
Hải Dương 72
Tianjin 72
Toronto 71
Zhengzhou 71
Biên Hòa 69
Modena 69
Abeokuta 67
Johannesburg 66
Olalla 66
Rimini 66
Rio de Janeiro 66
Falkenstein 65
Jiaxing 64
Can Tho 63
Totale 51.863
Salva come PNG Salva come JPEG
Nome #
18F-FDG PET/CT in visceral leishmaniasis: uptake patterns in the context of a multiannual outbreak in Northern Italy 1.738
MDR/XDR/PDR or DTR? Which definition best fits the resistance profile of Pseudomonas aeruginosa ? 1.055
[Prospective multicentre survey on clinical features and management approach to community-acquired pneumonia in emergency departments in Italy: focus on hospital admitted cases] 934
A multinational, preregistered cohort study of β-lactam/β-lactamase inhibitor combinations for treatment of bloodstream infections due to extended-spectrum-β-lactamase-producing enterobacteriaceae 560
Prognostic Value of the Fibrosis-4 Index in Human Immunodeficiency Virus Type-1 Infected Patients Initiating Antiretroviral Therapy with or without Hepatitis C Virus 481
Trend of microbiologically-confirmed tuberculosis in a low-incidence setting with high immigration rates 436
2017 WSES guidelines on colon and rectal cancer emergencies: Obstruction and perforation 415
Impact of social determinants on antiretroviral therapy access and outcomes entering the era of universal treatment for people living with HIV in Italy 392
Targeted Therapy of Severe Infections Caused by Staphylococcus aureus in Critically Ill Adult Patients: A Multidisciplinary Proposal of Therapeutic Algorithms Based on Real-World Evidence 370
Epidemiology and outcome of Clostridium difficile infections in patients hospitalized in Internal Medicine: findings from the nationwide FADOI-PRACTICE study. 366
Prevalence of Gastrointestinal Symptoms in Severe Acute Respiratory Syndrome Coronavirus 2 Infection: Results of the Prospective Controlled Multinational GI-COVID-19 Study 359
Incidence of hospital-acquired infections due to carbapenem-resistant Enterobacterales and Pseudomonas aeruginosa in critically ill patients in Italy: a multicentre prospective cohort study 330
Evaluation of the Kinetics of Antibody Response to COVID-19 Vaccine in Solid Organ Transplant Recipients: The Prospective Multicenter ORCHESTRA Cohort 328
2018 WSES/SIS-E consensus conference: Recommendations for the management of skin and soft-tissue infections 328
Impact of a newly established expert clinical pharmacological advice program based on TDM results in tailoring antimicrobial therapies hospital-wide in a tertiary university hospital: findings after the first-year of implementation 317
How important is obesity as a risk factor for respiratory failure, intensive care admission and death in hospitalised COVID-19 patients? Results from a single Italian centre 316
An evidence-based multidisciplinary approach focused at creating algorithms for targeted therapy of infection-related ventilator associated complications (IVACs) caused by Enterobacterales in critically ill adult patients 315
ACE2 and TMPRSS2 Potential Involvement in Genetic Susceptibility to SARS-COV-2 in Cancer Patients 300
Artificial Intelligence model to predict resistances in Gram-negative bloodstream infections 294
Prevalence and predictors of low bone mineral density and fragility fractures among HIV-infected patients at one Italian center after universal DXA screening: Sensitivity and specificity of current guidelines on bone mineral density management 291
Restriction Factors expression decreases in HIV-1 patients after cART 276
Gut microbiome dynamics and Enterobacterales infection in liver transplant recipients: A prospective observational study 274
The use of predictive scores in the management of patients with carbapenem-resistant Klebsiella pneumoniae infection 261
(18)F-FDG PET/CT diagnosis of unexpected extracardiac septic embolisms in patients with suspected cardiac endocarditis. 258
Antifungal prophylaxis in liver transplant recipients: one size does not fit all 256
A Case Report of Tolvaptan Therapy for ADPKD Patients with COVID-19. The Need for Appropriate Counselling for Temporary Drug Discontinuation 254
Relationship between immune response to SARS-CoV2 vaccines and development of breakthrough infection in solid organ transplant recipients: the CONTRAST cohort 254
Infections in liver and lung transplant recipients: A national prospective cohort 254
Epidemiology of Invasive Pulmonary Aspergillosis Among Intubated Patients With COVID-19: A Prospective Study 254
Spinal tuberculosis: Proposed spinal infection multidisciplinary management project (SIMP) flow chart revision 254
Prognostic Role of Bacterial and Fungal Infections in Patients with Liver Cirrhosis with and without Acute-on-Chronic Liver Failure: A Prospective 2-Center Study 252
Development and validation of a prediction model for severe respiratory failure in hospitalized patients with SARS-CoV-2 infection: a multicentre cohort study (PREDI-CO study) 249
A descriptive pharmacokinetic/pharmacodynamic analysis of continuous infusion ceftazidime-avibactam in a case series of critically ill renal patients treated for documented carbapenem-resistant Gram-negative bloodstream infections and/or ventilator-associated pneumonia 248
Impact of Continuous Infusion Meropenem PK/PD Target Attainment on C-Reactive Protein Dynamics in Critically Ill Patients With Documented Gram-Negative Hospital-Acquired or Ventilator-Associated Pneumonia 245
Assessing the impact of hepatitis C virus coinfection on lopinavir/ritonavir trough concentrations in HIV-infected patients. 243
Determination of Effective Albumin in Patients With Decompensated Cirrhosis: Clinical and Prognostic Implications 240
Combined computed tomography and fluorodeoxyglucose positron emission tomography in the diagnosis of prosthetic valve endocarditis: A case series 238
Carbapenem resistant bacteria in Intensive Care Unit during COVID-19 pandemic: Multicenter before-after cross sectional study 234
Pathological post-mortem findings in lungs infected with SARS-CoV-2 231
Vitamin E for the treatment of E-antigen-positive chronic hepatitis B in paediatric patients: results of a randomized phase 2 controlled study. 229
Impact on mortality of a bundle for the management of enterococcal bloodstream infection 229
Embracing tensions throughout crises: The case of an Italian university hospital during the COVID-19 pandemic 228
Seroprevalence of five neglected parasitic diseases among immigrants accessing five infectious and tropical diseases units in Italy: a cross-sectional study 227
Does Cytokine-Release Syndrome Induced by CAR T-Cell Treatment Have an Impact on the Pharmacokinetics of Meropenem and Piperacillin/Tazobactam in Patients with Hematological Malignancies? Findings from an Observational Case-Control Study 224
Efficacy of corticosteroid treatment for hospitalized patients with severe COVID-19: a multicentre study 224
Infectious diseases team for the early management of severe sepsis and septic shock in the emergency department 220
Recent Advances in the Evaluation of Serological Assays for the Diagnosis of SARS-CoV-2 Infection and COVID-19 219
Pharmacokinetic and pharmacodynamic considerations for optimizing antimicrobial therapy used to treat bone and joint infections: an evidence-based algorithmic approach 218
Chagas Disease in a Non-endemic Country: A Multidisciplinary Research, Bologna, Italy 216
Extended infusion of β-lactams for bloodstream infection in patients with liver cirrhosis: an observational multicenter study 216
Carbapenem-resistant Klebsiella pneumoniae colonization at liver transplantation:a management challenge 215
Significant Decrease in Plasma Levels of D-Dimer, Interleukin-8, and Interleukin-12 After a 12-Month Treatment with Rosuvastatin in HIV-Infected Patients Under Antiretroviral Therapy 213
Toscana virus infections in northern Italy: laboratory and clinical evaluation. 212
An Antimicrobial Stewardship Program Based on Systematic Infectious Disease Consultation in a Rehabilitation Facility 212
Epidemiological characteristics and management of Gram-negative bacteraemia in different immunocompromised hosts: Observational single-center study 211
Impact of attaining an aggressive PK/PD target with continuous infusion beta-lactams on the clinical efficacy of targeted therapy of early post-transplant Gram-negative infections in critically ill OLT recipients. An interim analysis of a 3-year prospective, observational, study 209
Role of 18F-FDG PET/CT in the diagnosis of infective endocarditis in patients with an implanted cardiac device: A prospective study 209
Risk factors for persistent enterococcal bacteraemia: a multicentre retrospective study 205
Management of immunosuppressive therapy in liver transplant recipients who develop bloodstream infection. 204
A prospective survey of febrile events in hematological malignancies. 203
Management of intra-abdominal infections: recommendations by the Italian council for the optimization of antimicrobial use 202
WSES consensus conference: Guidelines for first-line management of intra-abdominal infections. 202
PET con FDG nella dialisi peritoneale: le prospettive attuali e future 202
Calcaneal quantitative ultrasound (QUS) and dual X-ray absorptiometry (DXA) bone analysis in adult HIV-positive patients. 202
A descriptive case series of the relationship between maintenance of conservative PK/PD efficacy thresholds of dalbavancin over time and clinical outcome in long-term treatment of staphylococcal osteoarticular infections 201
A prospective, multicentre survey on antifungal therapy in neutropenic paediatric haematology patients 201
Superficial swab versus deep-tissue biopsy for the microbiological diagnosis of local infection in advanced-stage pressure ulcers of spinal-cord-injured patients: a prospective study 201
A proposal for a comprehensive approach to infections across the surgical pathway 201
Assessment of a pk/pd target of continuous infusion beta-lactams useful for preventing microbiological failure and/or resistance development in critically ill patients affected by documented gram-negative infections 201
Cefiderocol treatment for carbapenem-resistant Acinetobacter baumannii infection in the ICU during the COVID-19 pandemic: a multicentre cohort study 199
HIV-1 and recombinant gp120 affect the survival and differentiation of human vessel wall-derived mesenchymal stem cells 198
Differences in the rate of carbapenem-resistant Enterobacteriaceae colonisation or Clostridium difficile infection following frontline treatment with tigecycline vs. meropenem for intra-abdominal infections 198
Biopsy for suspected spondylodiscitis. 197
Computed tomographic pulmonary angiography for diagnosis of invasive mold diseases in patients with hematological malignancies 196
Dual raltegravir-darunavir/ritonavir combination in virologically suppressed HIV-1-infected patients on antiretroviral therapy including a ritonavir-boosted protease inhibitor plus two nucleoside/nucleotide reverse transcriptase inhibitors 196
Incidence and Prognosis of Ventilator-Associated Pneumonia in Critically Ill Patients with COVID-19: A Multicenter Study 195
Classification performance for covid patient prognosis from automatic ai segmentation—a single-center study 194
Impact of different antiretroviral strategies on total HIV-DNA level in virologically suppressed HIV-1 infected patients. 193
Risk factors for recurrent carbapenem resistant Klebsiella pneumoniae bloodstream infection: a prospective cohort study 193
Advances in the therapy of bacterial bloodstream infections 193
Blood neurofilament light chain and S100B as biomarkers of neurological involvement and functional prognosis in COVID-19: a multicenter study 192
Safety and effectiveness of fifth generation cephalosporins for the treatment of methicillin-resistant staphylococcus aureus bloodstream infections: a narrative review exploring past, present, and future 192
Paradoxical response to intravenous immunoglobulin in a case of Parvovirus B19-associated chronic fatigue syndrome 192
Plasmodium falciparum malaria in migrants who transited Libya - Where did they contract malaria? 192
Schistosoma mansoni eggs in spleen and lungs, mimicking other diseases 192
Burkholderia cepacia infection in an infant affected by renal osteodystrophy 192
Impact of a hospital-wide multifaceted programme for reducing carbapenem-resistant Enterobacteriaceae infections in a large teaching hospital in northern Italy 191
Liver decompensation predicts ribavirin overexposure in hepatitis C virus patients treated with direct-acting antivirals 191
A descriptive pharmacokinetic/pharmacodynamic analysis of continuous infusion ceftazidime-avibactam for treating DTR gram-negative infections in a case series of critically ill patients undergoing continuous veno-venous haemodiafiltration (CVVHDF) 190
Population pharmacokinetics and Monte Carlo simulation for dosage optimization of fosfomycin in the treatment of osteoarticular infections in patients without renal dysfunction 190
Comparative Impact of an Optimized PK/PD Target Attainment of Piperacillin-Tazobactam vs. Meropenem on the Trend over Time of SOFA Score and Inflammatory Biomarkers in Critically Ill Patients Receiving Continuous Infusion Monotherapy for Treating Documented Gram-Negative BSIs and/or VAP 189
Risk factors associated with bacteremia in COVID-19 patients admitted to intensive care unit: a retrospective multicenter cohort study 188
Impact of preoperative infection on outcome after liver transplantation 188
High-dose Weekly Liposomal Amphotericin B Antifungal Prophylaxis in Patients Undergoing Liver Transplantation 188
A pre-post quasi-experimental study of antimicrobial stewardship exploring the impact of a multidisciplinary approach aimed at attaining an aggressive joint pharmacokinetic/pharmacodynamic target with ceftazidime/avibactam on treatment outcome of KPC-producing Klebsiella pneumoniae infections and on ceftazidime/avibactam resistance development 187
Bloodstream infections in patients with liver cirrhosis 187
Bloodstream infection caused by KPC-producing Klebsiella pneumoniae resistant to ceftazidime/avibactam: epidemiology and genomic characterization 187
COVID-19 in patients with HIV-1 infection: a single-centre experience in northern Italy 187
Clinical phenotypes and quality of life to define post-COVID-19 syndrome: a cluster analysis of the multinational, prospective ORCHESTRA cohort 185
Efficacy of a Novel Prophylactic Scheme of Fosfomycin Trometamol in Patients Undergoing Endoscopic Surgery for Benign Prostatic Hyperplasia: Findings from a Prospective Monocentric Single-Arm Study 185
Totale 26.993
Salva come PNG Salva come JPEG
Categoria #
all - tutte 230.127
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 230.127
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.428 0 0 0 0 0 0 0 0 0 0 0 1.428
2021/20227.359 582 286 420 581 662 386 245 584 324 746 1.342 1.201
2022/20237.575 758 995 392 993 566 543 257 512 1.331 273 550 405
2023/20243.613 245 420 231 349 311 569 283 280 185 308 208 224
2024/202513.898 558 1.681 1.128 1.097 1.841 738 1.081 544 350 988 1.128 2.764
2025/202636.231 3.118 3.536 2.957 2.709 3.082 2.992 4.573 1.415 6.064 2.506 1.871 1.408
Totale 84.398